The STI hitting a record high, stronger trading volumes and SGX’s improving results all point to a genuine recovery in investor confidence. The biggest positive is the IPO pipeline, especially the growing presence of technology, healthcare and advanced manufacturing companies.
But I wouldn’t get too excited about the “50 IPOs” headline yet. The real test is what happens after listing. If new companies can attract institutional investors, build liquidity and trade above their IPO prices, confidence in SGX will improve significantly.
So my view is cautiously bullish: Singapore may be entering a new market cycle, but the next 12–18 months will determine whether this is a lasting revival or simply another short-term rally.
@SGX_Stars [龇牙]
Comments